Professor Chung-mau Lo was appointed Secretary for Health on 1 July 2022. Before joining the Government, he was Hospital Chief Executive at The University of Hong Kong-Shenzhen Hospital, Chair of Hepatobiliary & Pancreatic Surgery at The University of Hong Kong and Director of Liver Transplantation Centre at Queen Mary Hospital.

Professor Lo has devoted himself to clinical work, teaching and scientific research in the field of hepatobiliary surgery for more than three decades. He is internationally renowned for his expertise in hepatobiliary surgery and liver transplantation. He has published over 600 original articles in refereed international journals and his H-index is 94. His pioneering work in adult right lobe living donor liver transplantation has revolutionised the practice of liver transplant world-wide and has put Hong Kong on the world map of liver transplant. He and his team were awarded China’s top national honour of First-class State Scientific and Technological Progress Award in 2005.

He was the President of the International Liver Transplantation Society and the International Society for Digestive Surgery. He has served in the editorial board of many prestigious journals, including the American Journal of Transplantation, Liver Transplantation, Surgery and the Annals of Surgery. He has been elected as an Honorary Fellow of the American Surgical Association and Royal College of Surgeons in Ireland as well as an Honorary Member of the European Surgical Association.

Professor Lo served as the Hospital Chief Executive of The University of Hong Kong-Shenzhen Hospital from November 2016 to June 2022. Under the "One Country, Two Systems" strategy, he has actively leveraged the advantages of Shenzhen-Hong Kong cross-border collaboration to advocate "Green Healthcare Reform" in public hospitals, and to promote medical integration in the Greater Bay Area. Under his leadership, the Hospital became the youngest High-level Hospital of Guangdong Province in 2018 and received Shenzhen Municipal City Mayor's Quality Gold Award in 2020. The Hospital has been selected as a National High-Quality Development Hospital in 2021.

Tim is the Chief Operating Officer for The George Institute for Global Health, a medical research institute based in Sydney with major centres in China, India and the UK.  The Institute focuses on reducing the burden of chronic disease and injury, and its research has driven major improvements in the prevention and treatment of heart disease, stroke, diabetes, kidney disease, and many other conditions globally.

Tim is a Chartered Accountant with over 35 years' experience in the health, property and services industries.  Tim is former COO/CFO of ASX-listed Mirvac Group and has worked with the Sydney Olympic Games and PWC.

Tim is on the boards of Australia China and India Business Councils and is a Fellow of the Institute of Chartered Accountants, Australian Institute of Company Directors and Australian Property Institute.

Cameron van den Dungen is the Chief Executive Officer of Aged Care innovation and technology company, Sleeptite. Cameron brings a wealth of experience to the sleep and bedding industry as a Non-Executive Director of iconic Australian bedding retailer, Forty Winks and former General Manager of Bedding Australia. 

Cameron has spent over a decade scouring the world for research, technology and developments that would increase the quality of life for all Australians through a better night’s sleep. This led to the creation of Sleeptite and the focus on creating products that provide dignity to the lives of Australia’s elderly, while supporting the Australian Aged Care workforce.

With a career in media and marketing spanning more than a decade, he is also a passionate public speaker and advocate for Aged Care, sleep health and the Australian business landscape. He is also a proud member of the Australian Institute of Company Directors.

Professor Jean Yang is an applied statistician with expertise in statistical bioinformatics.  She was awarded the 2015 Moran Medal in statistics from the Australian Academy of Science in recognition of her work on developing methods for molecular data arising in cutting edge biomedical research.  Her research stands at the interface between medicine and methodology development and has centred on the development of methods and the application of statistics to problems in-omics and biomedical research.  She has made contributions to the development of novel statistical methodology and software for the design and analysis of high-throughput biotechnological data including that from microarrays, mass spectrometry and next generation sequencing.

Recently, much of her focus is on integration of multiple biotechnologies with clinical data to answer a variety of scientific questions.  This has led her to establish a Sydney D24H Hub as part of a global effort to build the Laboratory of Data Discovery for Health (D24H) which is funded by InnoHK, a major initiative of the Hong Kong Special Administrative Region Government.  Projects from this hub aim to curate massive, unique data resources and develops novel, deep, frontier analytics in protecting global public health and improving individual health care through precision medicine.  As a statistical data scientist who works in the interface of statistics, AI, biomedicine and health, she enjoys developing novel methods with industry translational potential in a collaborative environment, working closely with investigators from diverse backgrounds.

Andrew has nearly 30 years’ experience in the design, construction, commissioning/validation and operation of a wide range high tech facilities, including pharmaceutical manufacturing, high containment, industrial cleanroom, hospital pharmacy and specialist research facilities.This experience extends to facility layout, building fabric design, construction, and HVAC, utility and purified water specification. His project management experience encompasses all aspects of FDA, EU-TGA-PIC/s and associated regulations, local and international standards and general quality practices.He has performed gap analyses on many pharmaceutical manufacturing facilities and sterile/cytotoxic dispensing suites to assess aspects of compliance, safety, design and rectification.Andrew is a past president of ISPE (Australasia) and is active in establishing ISO standards. He is Independent Chair of ME-060 (Cleanroom Standards) for Standards Australia and committee member for TC-209 – (ISO 14644 and 14698 suite of standards).